DVTC:OTC-Development Technologies Corp (USD)

COMMON STOCK | Shell Companies |

Last Closing

USD 7.77

Change

0.00 (0.00)%

Market Cap

USD 0.42B

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Pegasus Pharmaceuticals Inc. manufactures and provides an advanced ECG system for the non-invasive screening of heart pathologies. The company offers HeartVue 6S System, which is a screening tool used to diagnose heart and other cardiac diseases. It serves cardiologists, general practitioners, physicians, intensive care units, hospitals, emergency rooms, clinics, fitness facilities, sports teams, and other emergency medical facilities. Pegasus Pharmaceuticals Inc. was founded in 1995 and is headquartered in Palm Beach Gardens, Florida.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-09 )

Largest Industry Peers for Shell Companies

Symbol Name Price(Change) Market Cap
PBAJ Petro Usa Inc

N/A

USD 1.00B
UHGI Ultimate Holdings Group Inc.

N/A

USD 0.61B
SCGX Saxon Capital Group Inc

N/A

USD 0.57B
WFHG World Financial Holding Group

N/A

USD 0.47B
DFHL Dong Fang Hui Le Inc

N/A

USD 0.45B
CAVG ACC Aviation Holdings Ltd

N/A

USD 0.42B
PUCKW Goal Acquisitions Corp

N/A

USD 0.32B
PUCKU Goal Acquisitions Corp Unit

N/A

USD 0.32B
LGYV Legacy Ventures International ..

N/A

USD 0.13B
APXI APx Acquisition I Corp

N/A

USD 0.11B

ETFs Containing DVTC

N/A

Market Performance

  Market Performance vs. Industry/Classification (Shell Companies) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -14.80% 34% F 27% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -14.80% 34% F 26% F
Trailing 12 Months  
Capital Gain 30.59% 72% C 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 30.59% 71% C- 77% C+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 17.44% 38% F 66% D+
Dividend Return 17.44% 38% F 63% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 104.48% 69% C- 31% F
Risk Adjusted Return 16.70% 41% F 55% F
Market Capitalization 0.42B 97% N/A 68% D+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.